D-Wave’s $100M Government Bet: Record Orders, Plunging Revenue, and the Battle for Profitability

D-Wave Q1 2026: Record bookings of $33.4M but revenue drops to $2.86M; net loss triples to $18.4M. Government grant provides liquidity.

D-Wave Quantum closed last week at €25.21 in Frankfurt, capping a 44% weekly surge that lifted the stock nearly 14% on Friday alone. The catalyst was unmistakable: a preliminary $100 million grant from the U.S. Department of Commerce, part of a $2 billion CHIPS and Science Act package earmarked for nine quantum computing firms. But beneath the rally lies a quarter of jarring contradictions — record bookings colliding with an 81% revenue collapse and a net loss that more than tripled.

The government funding comes with strings attached. Washington will take a minority stake in D-Wave, a structure that mirrors the equity-for-cash model deployed in semiconductor subsidies. The deal provides a critical liquidity cushion — D-Wave ended the first quarter with $588 million in cash and short-term investments, against a net cash position of roughly $553 million. Yet the operational burn remains intense: operating expenses doubled to $56.5 million in the quarter.

The financial statements for Q1 2026 paint a split portrait. Revenue plunged from $15.0 million a year earlier to $2.86 million, as the prior-year period had benefited from a high-margin system sale that was absent this time. The net loss widened from $5.4 million to $18.4 million. Gross margin, which had been a stellar 92.5%, contracted to 63.6% — a casualty of integration costs from the recently completed acquisition of Quantum Circuits and shifts in revenue recognition.

Yet order intake tells an entirely different story. New bookings surged nearly 2,000% to a record $33.4 million, powered by a single system sale worth $20 million and a $10 million corporate agreement. Remaining performance obligations leapt to over $42 million, more than half of which management expects to convert into revenue within the next twelve months.

The disconnect between bookings and reported revenue has become the central tension for investors. On a trailing twelve-month basis, D-Wave generated roughly $25 million in sales against a net loss of $355 million. The company’s annualized 30-day volatility stands at an extreme 148%, reflecting the market’s nervous embrace of the stock.

Wall Street remains broadly bullish. Needham and Cantor Fitzgerald each set price targets of $40, while Rosenblatt and Canaccord Genuity see the stock at $43 and $41, respectively. Mizuho is the notable holdout at $29. The average analyst target sits at $35.17, with a range from $19.58 to $45. Thirteen analysts rate the stock a buy; none recommend selling. Short sellers appear to be capitulating — the short interest as a percentage of float has dropped to 14.5%, suggesting bears are covering as the rally accelerates.

Not everyone at D-Wave is buying. On May 20, Chief People Officer Sophie Ames sold 23,025 shares through a pre-arranged 10b5-1 plan. Such sales are routine but can weigh on sentiment, especially when the stock is riding a wave of government-induced euphoria.

The next major test arrives on June 1, when D-Wave hosts its first investor day in New York under the banner “The D-Wave Difference.” Management is expected to unveil the technology roadmap and detail how the Quantum Circuits acquisition — which gives D-Wave both annealing and gate-model quantum computers — will be integrated. Before that, the company will field questions at TD Cowen’s conference on May 28, followed by appearances at Baird (June 3) and Rosenblatt (June 10). The question looming over each event: how will D-Wave translate its explosion in bookings into sustainable profitability, while the government’s equity stake adds a new variable to the capital structure?